default author photo

Sam Janes

University College London - Lung for Living Research Centre

SCHOLARLY PAPERS

2

DOWNLOADS

98

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Differentiating Clinically Important Interstitial Lung Abnormalities in Lung Cancer Screening

Number of pages: 37 Posted: 26 Jun 2024
The Francis Crick Institute, University College London - Lung for Living Research Centre, University College London - UCL Centre for Medical Imaging, University College London, University College London - UCL Centre for Medical Imaging, University College London - Lung for Living Research Centre, Bart's Health NHS Trust - The Royal London Hospital, University College London - Lung for Living Research Centre, University College London - Lung for Living Research Centre, University College London - Lung for Living Research Centre, University College London - Lung for Living Research Centre, University College London - Lung for Living Research Centre, University College London - Lung for Living Research Centre, University College London - Lung for Living Research Centre, University College London - Lung for Living Research Centre, University College London - Lung for Living Research Centre, University College London - University College London Hospitals NHS Foundation Trust, University College London - UCL Cancer Trials Centre, University College London - UCL Cancer Trials Centre, Imperial College London - National Heart and Lung Institute, University College London - University College London Hospitals, The Francis Crick Institute, University College London - Lung for Living Research Centre, University College London - Department of Computer Science, University College London, University College London - Centre for inflammation and Tissue Repair, University College London - UCL Cancer Trials Centre, Imperial College London - National Heart and Lung Institute, University College London - Lung for Living Research Centre and University College London
Downloads 68 (891,180)

Abstract:

Loading...

ILA, interstitial lung abnormality, pulmonary fibrosis, lung cancer screening

2.

Genetic Screens Reveal New Targetable Vulnerabilities in BAP1-Deficient Mesothelioma

Number of pages: 54 Posted: 01 Jul 2022
Netherlands Cancer Institute - Division of Molecular Genetics, Netherlands Cancer Institute - Division of Molecular Genetics, Radboud University Nijmegen - Department of Molecular Biology, Netherlands Cancer Institute - Division of Molecular Genetics, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, University College London - Lung for Living Research Centre, University College London - Lung for Living Research Centre, Radboud University Nijmegen - Department of Molecular Biology, Netherlands Cancer Institute - Division of Molecular Genetics and Netherlands Cancer Institute - Division of Molecular Genetics
Downloads 30 (1,332,057)

Abstract:

Loading...

Mesothelioma, BAP1, Polycomb, Mevalonate pathway, Epigenetics, Drug combinations, EZH2, Zoledronic acid